---
$id: https://graph.org.ai/products/commodity/51141519
$type: Product
source: UNSPSC
code: "51141519"
title: "Mephenytoin"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mephenytoin

**UNSPSC Code**: 51141519
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R420KW629U, chemically known as 2,4-imidazolidinedione, 5-ethyl-3-methyl-5-phenyl- but generally known as mephenytoin, which bears US NIH Compound Identifier 4060. European Medicines Agency schedules Mephenytoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08749MIG. The term MEPHENYTOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules mephenytoin in its Anatomical Therapeutic Chemical (ATC) Classification. MEPHENYTOIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mephenytoin under HS 29332100 and SITC 51572. As of Q4 2014, MEPHENYTOIN remains the US FDA Preferred Term for this commodity. Mephenytoin bears US NLM identifiers UMLS ID C0025381 and NCI Concept Code C66091. SMILES: CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2.

